CLARIVATE (CLVT) revenue breakdown
By segment, A&G is the largest at 52% of fiscal 2025 revenue, growing 27% a year over 5 years.
By product, Subscription revenues is the largest at 65% of fiscal 2025 revenue, growing -0% a year over 3 years.
Revenue by segment
Fiscal years, as CLARIVATE reports them in its 10-K filings; fiscal 2025 total $2.5B.
| Segments | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|---|---|---|
| A&G | — | — | $385M | $489M | $1.3B | $1.3B | $1.3B | $1.3B | 52% |
| IP | $442M | $427M | $517M | $974M | $927M | $863M | $811M | $799M | 33% |
| Life Sciences & Healthcare | — | — | $352M | $413M | $453M | $443M | $419M | $390M | 16% |
| Science Segment | $526M | $548M | — | — | — | — | — | — | — |
Revenue by product
Fiscal years, as CLARIVATE reports them in its 10-K filings; fiscal 2025 total $2.5B.
| Products | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|
| Subscription revenues | $1.6B | $1.6B | $1.6B | $1.6B | 65% |
| Re-occurring Revenues | $442M | $445M | $430M | $434M | 18% |
| Transactional and other revenues | $599M | $566M | $500M | $416M | 17% |
Revenue by region
Fiscal years, as CLARIVATE reports them in its 10-K filings; fiscal 2025 total $2.5B.
| Regions | 2019 | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|---|
| North America | $463M | $925M | $1.5B | $1.4B | $1.4B | $1.3B | 53% |
| EMEA | $279M | $556M | $698M | $708M | $668M | $655M | 27% |
| Asia Pacific | $233M | $396M | $499M | $516M | $508M | $497M | 20% |
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for CLVT.
Open CLVT in InvestinglyQuestions
Where does CLARIVATE make its money?
In fiscal 2025, by segment: A&G $1.3B, IP $799M, Life Sciences & Healthcare $390M.
From CLARIVATE's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.